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The ubiquitin ligase CHIP (carboxyl terminus of Hsp70-interacting protein) regulates protein quality control, and CHIP dele-
tion accelerates aging and reduces the life span in mice. Here, we reveal a mechanism for CHIP’s influence on longevity by dem-
onstrating that CHIP stabilizes the sirtuin family member SirT6, a lysine deacetylase/ADP ribosylase involved in DNA repair,
metabolism, and longevity. In CHIP-deficient cells, SirT6 protein half-life is substantially reduced due to increased proteasome-
mediated degradation, but CHIP overexpression in these cells increases SirT6 protein expression without affecting SirT6 tran-
scription. CHIP noncanonically ubiquitinates SirT6 at K170, which stabilizes SirT6 and prevents SirT6 canonical ubiquitination
by other ubiquitin ligases. In CHIP-depleted cells, SirT6 K170 mutation increases SirT6 half-life and prevents proteasome-medi-
ated degradation. The global decrease in SirT6 expression in the absence of CHIP is associated with decreased SirT6 promoter
occupancy, which increases histone acetylation and promotes downstream gene transcription in CHIP-depleted cells. Cells lack-
ing CHIP are hypersensitive to DNA-damaging agents, but DNA repair and cell viability are rescued by enforced expression of
SirT6. The discovery of this CHIP-SirT6 interaction represents a novel protein-stabilizing mechanism and defines an intersec-
tion between protein quality control and epigenetic regulation to influence pathways that regulate the biology of aging.
Although aging was once perceived as a consequence of “wearand tear” on tissues and cells, the process of aging is now
understood to be a coordinated decline in cellular energy metab-
olism, DNA repair, protein quality control (PQC), and antioxi-
dant capacity (1–3). Understanding the cell biology behind aging
has led to the identification of proteins actively involved in pro-
cesses that prevent or promote an overall aging phenotype. CHIP
(carboxyl terminus of Hsp70-interacting protein) is a protein that
exhibits both cochaperone and ubiquitin ligase activities and is an
integral component of PQC (4). We have previously reported that
CHIP/ mice exhibit reduced life span and many aging hall-
marks, including muscle wasting, osteoporosis, early cellular se-
nescence, and accumulation of misfolded proteins and oxidized
lipids (5). Although this phenotype clearly implies a protective
role for CHIP in the process of aging, the mechanism behind
CHIP’s support of cellular longevity remains unknown.
Many cellular stressors have deleterious effects on protein sta-
bility, causing either misfolding or aggregation (6), and PQC me-
diates the removal of damaged or aggregated proteins. CHIP is a
key player in PQC and prevents proteotoxicity through dual
mechanisms. At the onset of acute stress, CHIP activates heat
shock factor 1 (HSF1), the transcription factor responsible for
upregulating expression of chaperone proteins (7). CHIP nuclear
localization increases dramatically during acute stress, but CHIP’s
nuclear functions beyond HSF1 activation are currently unclear.
CHIP then partners with newly transcribed heat shock proteins
via CHIP’s tetracopeptide repeat (TPR) domain, which promotes
substrate refolding into proper conformation. CHIP also contains
a C-terminal U-box domain that confers ubiquitin ligase activity
and promotes ubiquitination of chaperone-associated proteins
(8). After misfolded protein substrates have been depleted via pro-
teasomal degradation, CHIP is responsible for the ubiquitination
and degradation of excess heat shock proteins (9).
CHIP catalyzes the formation of canonical ubiquitin chains
(linked through ubiquitin lysine 48 [K48] residues) to promote deg-
radation of a broad array of targets, including cystic fibrosis trans-
membrane receptor (10), HER2/neu receptor (11), SMAD1/4 (12),
and aggregate-prone proteins such as -synuclein (13) and tau (14).
However, CHIP can also form noncanonical ubiquitin chains that are
linked through other lysine residues (15) that have diverse, nonpro-
teasomal signaling functions (16). Recently, we described CHIP’s
noncanonical ubiquitination of the transcriptional corepressor Daxx,
which promotes Daxx’s translocation to an insoluble cellular com-
partment and prevents Daxx sumoylation, required for Daxx activity
(17). However, it remains to be seen whether CHIP noncanonically
ubiquitinates other targets and if there is a functional consequence of
this activity.
In an effort to better understand the anti-aging function of
CHIP, we sought to identify novel CHIP-interacting proteins that
may provide an understanding of CHIP’s effects on longevity and
senescence. To this end, we have identified an interaction between
CHIP and the sirtuin family isoform Sirtuin 6 (SirT6). In this
report, we demonstrate that SirT6 interacts with CHIP and serves
as a noncanonical ubiquitination substrate for CHIP, which pre-
vents SirT6 protein degradation and allows SirT6 to participate in
its previously described roles of DNA repair and histone deacety-
lation. This newly uncovered mechanism expands the current un-
derstanding of the biology of both CHIP and SirT6 and offers an
exciting interpretation of CHIP’s ability to influence longevity.
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MATERIALS AND METHODS
Reagents and antibodies. All chemicals and reagents were obtained from
Sigma unless otherwise noted. Western blots were performed using
NuPage Bis-Tris gels and an electrophoresis system (Invitrogen), trans-
ferred to 0.45-m-pore-size polyvinylidene difluoride (PVDF) mem-
branes (Millipore), and visualized using ECL Advance (GE Healthcare)
on an EpiChemi 3 Darkroom (UVP), and band densitometry was ana-
lyzed using ImageJ. A table of antibodies used in these experiments can be
found in the supplemental material.
Cell culture, plasmid transfection, and immunoprecipitation.
CHIP/ and CHIP/ mouse embryonic fibroblasts (MEFs) were cul-
tured as previously described (7). HEK 293 cells were cultured in high-
glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS). Transfections in 293
FIG 1 SirT6 protein is stabilized in the presence of CHIP. (A) SirT6 expression was analyzed via Western blot analysis in multiple tissues from 12-month-old
CHIP/ and CHIP/ mice. Skel., skeletal. (B) Endogenous SirT6 and CHIP protein expression was measured in shControl and shCHIP 293 cells (left) and in
CHIP/ and CHIP/ MEFs (right) via Western blot analysis. SirT6 protein quantification (middle) and mRNA quantification (bottom) are shown (n  4).
(C) Normal 293 cells were transiently transfected with control siRNA, two independent siRNAs targeting CHIP, or SirT6 siRNA. CHIP and SirT6 protein were
measured via Western blot analysis, and SirT6 protein quantification (middle) and mRNA quantification (bottom) are shown (n  3). (D) shControl and
shCHIP 293 cells stably expressing FLAG-SirT6 were exposed to dimethyl sulfoxide (DMSO), actinomycin, chloroquine, cycloheximide, MG132, or ammonium
chloride (NH4Cl) for 16 h. SirT6 protein levels were visualized in Western blots, quantified, and normalized to the DMSO control for each cell type (n  3).
(Right) Representative Western blot from cells treated with MG132. The proteasome-regulated protein p27 is shown to indicate MG132 effectiveness. (E)
shCHIP cells were exposed to DMSO or MG132 for 16 h, and Endogenous SirT6 protein levels were measured via Western blotting. p27 indicates MG132
treatment. (Top) Representative Western blot. (Bottom) Quantification (n  4). Results represent means and SEM. *, P  0.05. Graphed results represent SirT6
protein relative to -tubulin and normalized to control in arbitrary units.
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cells were performed using FuGENE 6 (Roche) or X-TremeGene 9
(Roche). Plasmids were introduced into MEFs through electroporation
with the Amaxa MEF Nucleofector 2 kit (Lonza) using program A23.
Empty vector (pcDNA3.1), FLAG-tagged plasmids expressing sirtuin
family isoforms (Addgene plasmids 13812 to 13818 [18]), Myc-tagged
wild-type (WT) CHIP, TPR CHIP, H260Q CHIP, U-box CHIP, hem-
agglutinin (HA)-WT ubiquitin, and HA-K48R ubiquitin constructs were
described previously (8, 17). His-tagged WT SirT6 cloned into pQE-80
(Addgene plasmid 13739 [19]) and FLAG-tagged SirT6 cloned into
pCMV (Addgene plasmid 13817 [18]) were used as templates with the
QuikChange II site-directed mutagenesis kit (Agilent) to produce the
K170R SirT6 plasmids that were expressed in bacterial and mammalian
cells, respectively. Cell lysates were harvested on ice with lysis buffer (50
mM Tris, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, protease
inhibitor [Complete; Roche]), and insoluble material was pelleted by cen-
trifugation at 8,000 	 g. Phosphatase inhibitor was added to lysis buffer
for phosphorylated replication protein A (RPA) measurements (Phos-
Stop; Roche). FLAG and Myc immunoprecipitations were performed
for 16 h in lysis buffer using EZView anti-FLAG affinity gel and EZ-
View anti-c-Myc affinity gel (Sigma). For measurement of HA-tagged
ubiquitination, cells were transfected as described above, and all cells
were cultured in 5 M the proteasome inhibitor MG132 for 16 h prior
FIG 2 CHIP and SirT6 stably interact through the CHIP U-box domain. (A) HEK 293 cells were transfected with Myc-tagged CHIP (Myc-WT CHIP) and
FLAG-tagged sirtuin isoforms 1 to 7 (FLAG-SirT). Input (above) and FLAG immunoprecipitation (IP) (below) were performed on cell lysates and visualized via
Western blotting with the indicated antibodies. (B) Endogenous CHIP was immunoprecipitated from HEK 293 cell lysates, and endogenous SirT6 was detected
and visualized via Western blotting. (C) HEK 293 cells transfected with Myc-WT CHIP and FLAG-SirT6 were incubated at 37°C or 42°C for 30 min. Nuclear
fractions were immediately prepared, and input and Myc immunoprecipitations were visualized via Western blotting with the indicated antibodies. (D) The
indicated Myc-tagged CHIP constructs (diagrammed) were transfected into HEK 293 cells with FLAG-SirT6. Input and Myc immunoprecipitations were
performed on cell lysates and visualized via Western blotting. (E and F) shCHIP 293 cells (E) and CHIP/ MEFs (F) were transfected with Myc-WT CHIP,
Myc-U-box CHIP, or Myc-H260Q CHIP. Lysates were collected, and endogenous SirT6 expression was quantified via Western blot analysis (right; n  4 of
each). NS, nonspecific band. The results represent means and SEM. *, P  0.05. Graphed results represent SirT6 protein relative to -tubulin and normalized to
control in arbitrary units.
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to harvest and then harvested in lysis buffer containing 10 mM N-
ethylmaleimide. Nuclear fractions were prepared using the NE-PER
kit (Pierce).
Immunofluorescence. Cell staining was performed as previously de-
scribed (20) with modifications described in the supplemental material.
Stable cell lines. Stable HEK 293 cell lines were created via transduc-
tion with Mission lentiviral short hairpin RNA (shRNA) (Sigma) target-
ing CHIP or a scrambled control. Cells were selected with puromycin (1
g/ml) for 14 days, and CHIP knockdown was verified via quantitative
PCR (qPCR) and Western blotting. The cells were then transfected with
pcDNA3.1 or FLAG-SirT6 using FuGene 6, and stable expression was
selected using neomycin (Gibco; 700 g/ml) for 14 days.
In vitro ubiquitination. Each in vitro ubiquitination reaction was
performed using 2.5 M recombinant CHIP, 1 M recombinant WT
SirT6, or recombinant K170R SirT6 (both purified using a HisTalon grav-
ity purification kit [Clontech]), and the following reagents where indi-
cated: 50 nM Ube1, 2.5 M UbcH5c, 250 M WT or mutant lysine ubiq-
uitin, 20 nM purified 26S proteasome, and 2.5 mM Mg-ATP (all from
Boston Biochem) in reaction buffer (50 mM Tris-HCl, pH 7.6, 50 mM
KCl, 0.2 mM dithiothreitol [DTT]). Reactions were performed for 1 h at
37°C. Samples were separated and visualized via Western blot analysis.
mRNA analysis. mRNA was isolated using the RNeasy Mini kit (Qia-
gen) and reverse transcribed using an Iscript cDNA synthesis kit (Bio-
Rad). Real-time PCR was performed using Roche LightCycler 480 Probes
Master Mix, Roche Universal Probe Library probes, and primers targeting
the indicated genes (Integrated DNA Technologies) (see Table S4 in the
supplemental material). Amplification was measured on a Roche Light-
Cycler 480 instrument.
FIG 3 CHIP ubiquitinates SirT6 with noncanonical chains at K170. (A) shControl and shCHIP 293 cells stably expressing FLAG-SirT6 were transfected with
HA-tagged WT ubiquitin (Ub) or HA-tagged K48R ubiquitin and cultured in MG132 for 16 h. Protein levels of input and FLAG-immunoprecipitated samples
were visualized via Western blot analysis. The K48R/WT ubiquitination ratio is shown below (n  3). (B to E) In vitro ubiquitination reactions were performed
using recombinant CHIP, SirT6, and ubiquitin. Reaction mixtures containing WT ubiquitin (B), WT ubiquitin or ubiquitin mutants with the indicated lysines
mutated to arginine (C), WT ubiquitin or ubiquitin mutants in which the lysine indicated is the only lysine available for ubiquitination (D), or WT ubiquitin or
K48-only ubiquitin with the addition of purified 26S proteasome (E) were used to perform ubiquitination reactions and visualized via Western analysis;
representative images of at least 3 experiments are shown. (F) Monoubiquitinated SirT6 was analyzed using LC–MS-MS, and a single ubiquitination modification
was discovered at K170. (G) In vitro ubiquitination reactions were performed using CHIP, WT ubiquitin, and WT SirT6 or K170R SirT6. For all ubiquitination
reactions, representative images are shown (n  3). The results represent means and SEM. *, P  0.05. Graphed results represent SirT6 protein relative to
-tubulin and normalized to control in arbitrary units.
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SirT6 half-life measurement. Half-life was measured via pulse-chase
labeling with 35S-labeled amino acids as previously described (21) with
modifications shown in the supplemental material.
Chromatin immunoprecipitation. Chromatin immunoprecipitation
(ChIP) was performed using the Magna ChIP A/G kit (Millipore) (see the
supplemental material for details).
Viability assays. Stable HEK 293 cell lines were cultured in the pres-
ence of 100 to 300 M methyl methanesulfonate (MMS) or 200 to 600
M hydrogen peroxide (H2O2) for 6 days. The cells were then stained
with trypan blue and counted with a hemocytometer. Immortalized
CHIP/ and CHIP/ MEFs were grown in 96-well plates and incu-
bated in 3-aminobenzamide (10 mM), camptothecin (1 M), or paraquat
(0.5 mM) for 16 h. Viability was assessed using an MTS assay (Promega).
Statistics. Unless otherwise indicated, Student’s t test was used to as-
sess significance (Excel). The Fisher exact test was performed for analysis
of 
H2AX focus distribution (R-Stat). Excluding ChIP-sequencing
(ChIP-seq) data, all experiments were performed on at least three inde-
pendent occasions, with representative Western blots shown. Graphed
results represent means and standard errors of the mean (SEM).
RESULTS
SirT6 protein stability is decreased in the absence of CHIP. We
sought to understand the molecular mechanisms responsible for
the severe aging phenotype of the CHIP/ mouse (5, 7). Because
CHIP activates HSF1, we hypothesized that if the aging phenotype
was mediated entirely through decreased HSF1 activity, the
HSF1/ mouse should show pathologies similar to those of the
CHIP/ mouse. Although there are some similarities reported in
HSF1/ mice, such as growth retardation, decreased Hsp70 ex-
pression, and neural protein aggregation (22–24), the range of
unique pathologies observed in the CHIP/ mice indicated that
CHIP might regulate aging through multiple mechanisms. Several
aging-related phenotypes observed in SirT6/ mice, including
small size, decreased bone mineral density, lordokyphosis, loss of
subcutaneous fat, senescence-associated -galactosidase staining,
spontaneous cardiac hypertrophy, and reduced life span (25–27),
are shared by CHIP/ mice. Therefore, we hypothesized that
SirT6 protein activity might be affected by the loss of CHIP. We
measured SirT6 mRNA and protein levels in several tissues from
12-month-old CHIP/ and CHIP/ mice. Although SirT6
mRNA levels were unchanged in tissues from CHIP/ mice (un-
published observations), SirT6 protein levels were dramatically
reduced in most CHIP/ tissues (Fig. 1A). The exception to this
was skeletal muscle, in which SirT6 levels were unaffected by the
absence of CHIP, suggesting that the proteins involved in SirT6
regulation may not be active in this tissue. To further study the
connection between CHIP and SirT6, HEK 293 cells were devel-
oped to stably express a scrambled shRNA (shControl) or an
FIG 4 Mutant SirT6 has improved stability in CHIP-depleted cells. (A) shControl and shCHIP cells were cotransfected with green fluorescent protein (GFP) and
WT SirT6 or K170R SirT6. Forty-eight hours later, the levels of transfected proteins were visualized via Western blotting, and SirT6 levels were calculated relative
to GFP as an internal transfection control (below; n  3). (B) Pulse-chase assays using 35S-labeled methionine/cysteine were used to measure protein half-lives
of WT SirT6 and K170R SirT6 in shControl and shCHIP cells expressing FLAG-tagged SirT6 constructs. Following FLAG immunoprecipitation and autora-
diography, protein levels were calculated at the indicated time points. Representative autoradiography images are shown below the corresponding graphs (n 
3). (C) WT SirT6 and K170R SirT6 were transiently expressed to achieve similar protein expression in shControl and shCHIP 293 cells and then split and treated
for 16 h with DMSO or MG132. SirT6 protein levels were measured via Western blotting. The accumulation of WT SirT6 or K170R SirT6 caused by MG132 for
each cell condition was quantified and expressed relative to DMSO treatment (below; n  3). The results represent means and SEM; *, P  0.05. Graphed results
represent SirT6 protein relative to -tubulin and normalized to control in arbitrary units.
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shRNA pool targeting CHIP (shCHIP). We examined SirT6
mRNA in 293 cells and in immortalized CHIP/ and CHIP/
MEFs, and in accordance with the decreased SirT6 protein expres-
sion observed in CHIP/ tissues, we observed decreased SirT6
protein levels in both the CHIP-depleted 293 cells and MEFs (Fig.
1B). However, CHIP depletion had no effect on SirT6 mRNA in
either cell type (Fig. 1B), indicating a completely posttranslational
effect. We also transiently reduced expression of CHIP in 293 cells
using two individual CHIP-targeting small interfering RNAs
(siRNAs) and found that a reduction in CHIP correlated with a
reduction in SirT6 protein levels; however, CHIP siRNA had no
effect on SirT6 mRNA levels (Fig. 1C). Together, these data sug-
gest that SirT6 stability is positively related to the presence of
CHIP. To better characterize the mechanism by which SirT6 pro-
tein is stabilized by CHIP, SirT6 protein levels were measured in
shControl and shCHIP cells stably expressing FLAG-SirT6 follow-
ing 16 h of treatment with chemical inhibitors of transcription,
translation, proteasome activity, and autophagy (Fig. 1D). The
inhibitors showed no substantial effects on SirT6 protein levels in
the cells expressing CHIP. However, in shCHIP cells, the protea-
some inhibitor MG132 increased expression of FLAG-SirT6, in-
dicating that CHIP prevents proteasome-dependent degradation
of SirT6. We also found that endogenous SirT6 accumulated with
MG132 treatment in shCHIP cells (Fig. 1E). Together, these data
indicate that CHIP depletion increases proteasome-mediated
SirT6 degradation and suggest that CHIP protects SirT6 protein
from proteasomal degradation.
CHIP interacts with SirT6, and CHIP ubiquitin ligase activ-
ity increases SirT6 expression. Since CHIP has many substrates,
it is possible that CHIP’s effect on SirT6 stability is mediated
through an indirect mechanism, such as inhibition of a negative
regulator of SirT6. However, it is also possible that CHIP interacts
directly with SirT6 to influence protein stability. We screened
CHIP for interactions with all seven sirtuin isoform members, a
family of proteins that generally promote cell homeostasis and
affect the rate of aging by regulating the cell cycle, DNA repair, and
metabolism through NAD-dependent lysine deacetylase (KDAC)
or ADP ribosylase activity (28). Using coexpression and immuno-
precipitation of tagged CHIP and sirtuin proteins, we found that
CHIP stably interacted solely with SirT6 (Fig. 2A). We also found
that endogenous CHIP and SirT6 stably interacted (Fig. 2B).
Given that SirT6 is a nuclear protein and that CHIP’s nuclear
localization increases at the onset of stress (20), we hypothesized
that the CHIP-SirT6 interaction would increase with stress due to
CHIP nuclear accumulation. Nuclear extracts freshly prepared
from cells exposed to elevated culture temperatures demonstrated
increased CHIP nuclear localization, which allows more SirT6 to
coimmunoprecipitate with CHIP within the nuclear compart-
ment (Fig. 2C).
We hypothesized that the CHIP domain responsible for the
interaction with SirT6 might hint at the nature of CHIP’s regula-
tory effect on SirT6. In coexpression/immunoprecipitation exper-
iments using WT CHIP and CHIP domain mutants, we found that
SirT6 associates with a CHIP construct lacking the TPR domain
(TPR CHIP) and with a CHIP mutant that has an inactivating
point mutation in the U-box domain (H260Q CHIP) but not with
a CHIP mutant lacking the entire U-box domain (U-box CHIP
[Fig. 1D]). This indicates that CHIP’s intact U-box domain is
required for interaction with SirT6.
We next tested whether reintroduction of CHIP in CHIP-de-
pleted cells could increase SirT6 protein levels. As shown in Fig. 2E
and F, transient transfection of WT CHIP into shCHIP cells (Fig.
2E) or CHIP/ MEFs (Fig. 2F) demonstrated that reintroduction
of WT CHIP increased SirT6 protein expression. Furthermore,
ectopic expression of WT CHIP had no effect on SirT6 mRNA
levels (data not shown), indicating that the manner in which WT
CHIP overexpression increases SirT6 protein expression is medi-
ated at a posttranslational level. Expression of U-box CHIP,
which can interact with heat shock proteins but has no ubiquitin
ligase activity and does not interact with SirT6, had no effect on
SirT6 protein levels. However, expression of H260Q CHIP, which
stably interacts with SirT6 but has no ubiquitin ligase activity, also
had no effect on SirT6 protein levels, demonstrating that the
CHIP-SirT6 interaction alone is not sufficient to increase SirT6
stability. Taken together, these data demonstrate that SirT6 pro-
tein stability is positively correlated with the presence of CHIP and
requires CHIP’s ubiquitin ligase activity. This suggests that CHIP
could stabilize SirT6 indirectly by degrading a negative regulator
of SirT6, or alternatively, CHIP could stabilize SirT6 through non-
canonical ubiquitination, a mechanism previously described for
CHIP’s effect on Daxx (17).
CHIP noncanonically ubiquitinates SirT6 at K170. Because
CHIP and SirT6 stably interact and CHIP ubiquitin ligase activity
is required to enhance SirT6 stability, we hypothesized that CHIP
noncanonically ubiquitinates SirT6. To determine the contribu-
tion of CHIP to SirT6 ubiquitination, shControl and shCHIP cells
stably expressing FLAG-SirT6 were transiently transfected with
HA-tagged WT ubiquitin or K48R mutant ubiquitin, which can-
not form canonical linkages associated with proteasomal degrada-
tion. All cells were incubated in proteasome inhibitor prior to
harvest and lysed in the presence of a deubiquitinase inhibitor to
preserve SirT6 ubiquitination. As shown in Fig. 3A, immuno-
precipitation analysis demonstrated SirT6 ubiquitination in
both shControl and shCHIP cells transfected with WT ubiqui-
tin (lanes 3 and 5). However, polyubiquitination involving
K48R ubiquitin (noncanonical ubiquitination; lanes 4 and 6) oc-
curred in shControl cells only, suggesting that CHIP is required
for noncanonical ubiquitination of SirT6. Furthermore, the ca-
nonical ubiquitination of SirT6 in the absence of CHIP suggests
the involvement of another, as yet unidentified ubiquitin ligase.
FIG 5 CHIP depletion decreases SirT6 and increases H3K9Ac promoter occupancy. (A) H3K9Ac was measured and expressed relative to total H3 via Western
blot analysis in shControl and shCHIP 293 cells and in CHIP/ and CHIP/ MEFs. Quantification is shown on the right of each Western blot (n  3). (B and
C) Analysis of H3K9Ac ChIP-seq data from shControl and shCHIP cells was performed by Ingenuity pathway analysis (B) and TRANSFAC (C), using peaks
associated with the 5= regions of annotated genes. (D and E) ChIP-qPCR for endogenous SirT6 (D) and H3K9Ac (E) was performed in shControl cells, shCHIP
cells, or shCHIP cells overexpressing WT CHIP (shCHIPCHIP). Protein enrichment within the promoter regions of the indicated genes was calculated relative
to input and normalized to shControl levels (n  3). (F and G) Real-time PCR was used to measure mRNA in 293 cells used in ChIP studies (F) and livers from
CHIP/ and CHIP/ mice (n  3) (G). (H and I) shControl and shCHIP cells were transfected with vector, WT SirT6, or K170R SirT6 constructs; 48 h later,
RNA was isolated. BIRC3 mRNA (H) and LDHB mRNA (I) were measured by qPCR and calculated relative to 18S (n  3). The results represent means and SEM;
*, P  0.05.
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Taken together, these results indicate that CHIP competes with
other ubiquitin ligases to regulate SirT6 stability.
To test whether CHIP directly ubiquitinates SirT6, we per-
formed in vitro ubiquitination reactions with recombinant CHIP,
SirT6, and ubiquitin proteins. As shown in Fig. 3B, we found that
SirT6 is a substrate for CHIP-mediated polyubiquitination. We
then employed a variety of ubiquitin mutants to determine
whether CHIP demonstrates a preferential ubiquitin linkage. As
shown in Fig. 3C, we first used ubiquitin mutants in which the
indicated lysine had been mutated to arginine and found that
SirT6 could be ubiquitinated by any of these arginine mutation
molecules, including K48R (indicative of a noncanonical chain),
or even by a ubiquitin molecule lacking K29, K48, and K63 (3K).
Furthermore, in vitro reactions with ubiquitin mutants expressing
a single lysine demonstrated that CHIP can polyubiquitinate
SirT6 with chains linked through any individual lysine (Fig. 3D).
This is entirely consistent with previous data demonstrating that
CHIP and its partner E2 enzyme, UbcH5, can ubiquitinate a
model substrate with a variety of linkages (15) and suggests that
CHIP might directly decorate SirT6 with noncanonical ubiquitin
chains. Furthermore, as shown in Fig. 3E, addition of purified 26S
proteasome to an in vitro ubiquitination assay mixture containing
WT ubiquitin did not lead to the disappearance of ubiquitinated
SirT6; however, there was a reduction in ubiquitinated SirT6
when a canonical chain was added by including a ubiquitin mu-
tant expressing lysine at position 48 only (K48). Together these
data indicate that CHIP can ubiquitinate SirT6 and most likely
does so with noncanonical chains.
To identify the target residue within SirT6 that is modified by
CHIP-dependent ubiquitination, in vitro ubiquitination reactions
using CHIP, SirT6, and WT ubiquitin were separated by gel elec-
trophoresis, and the resulting gel was stained. Trypsin digestion of
the band corresponding to monoubiquitinated SirT6 followed by
liquid chromatography-tandem mass spectrometry (LC–MS-MS)
analysis revealed a single ubiquitination site at K170 (Fig. 3F),
which is found within the core sirtuin domain (29) and is con-
served across human, rodent, chicken, and bovine SirT6 ortholog
protein sequences. We mutated the lysine at position 170 in WT
SirT6 to arginine (K170R SirT6) to determine whether this residue
contributes to overall SirT6 protein stability. In vitro ubiquitina-
tion reactions demonstrated that recombinant K170R SirT6 is ca-
pable of being polyubiquitinated (Fig. 3G). This was somewhat
surprising, as we expected to observe less ubiquitination on
K170R SirT6. However, there are several possible interpretations
of these results. One possibility is that CHIP’s physical interaction
with SirT6 promotes ubiquitination on one of the 18 other avail-
able lysine residues when K170 is not available, which may or may
not be important in determining SirT6 stability. Because K170 is
the preferred ubiquitination site, another possibility is that the
remaining lysine residues in K170R SirT6 are not as readily ubiq-
uitinated, but the reaction kinetics of in vitro ubiquitination are
too rapid to detect a difference in ubiquitination in the short time
frame of this experiment. In either case, the next logical step is to
determine the stability of K170R SirT6 in cells with varying CHIP
expression. Together, the data in Fig. 3 support the notion that
CHIP ubiquitinates SirT6 at K170 with noncanonical chains and
suggest that this might be a regulatory mechanism in determining
SirT6 stability.
SirT6 K170 mediates susceptibility to protein degradation in
the absence of CHIP. To determine whether SirT6 K170 has any
effect on overall protein stability, we introduced WT SirT6 and
K170R SirT6 in shControl and shCHIP cells and compared ex-
pression levels. We found that although WT SirT6 is less stable in
the absence of CHIP, K170R SirT6 expression is unaffected by the
presence or absence of CHIP (Fig. 4A). To directly quantify
CHIP’s effect on SirT6 protein stability, WT SirT6 and K170R
SirT6 protein half-lives were measured via pulse-chase labeling
experiments using 35S-labeled amino acids. Loss of CHIP reduced
the WT SirT6 protein half-life by 43% (from 48 h in shControl
cells to 27 h in shCHIP cells) (Fig. 4B). However, the K170R mu-
tation completely rescued the SirT6 half-life in CHIP-depleted
cells, so that the calculated half-life of K170R SirT6 in the presence
or absence of CHIP was similar to the half-life of WT SirT6 in
shControl cells (Fig. 4B).
Our data indicate that, in the absence of CHIP, SirT6 is canon-
ically ubiquitinated (Fig. 3A) and degraded by the proteasome
(Fig. 1D and E), which reduces WT SirT6 protein stability (Fig. 4A
and B). To confirm whether K170R SirT6 is less susceptible to
proteasomal degradation, we compared the effects of MG132
treatment on accumulation of WT SirT6 and K170R SirT6 in
shControl and shCHIP cells. If K170 is the main site for canonical
ubiquitination by a ubiquitin ligase competing with CHIP, it is
assumed that mutation of this lysine would prevent MG132-in-
duced SirT6 accumulation in CHIP-depleted cells. To control for
differences in protein accumulation due to differences in initial
protein levels, we employed a transient-transfection strategy so
that the levels of FLAG-SirT6 expression were similar across all
conditions and then split the cells and added vehicle or MG132 for
16 h. In shControl cells, proteasome inhibition did not lead to a
statistically significant accumulation of either WT or K170R SirT6
(Fig. 4C), consistent with our data demonstrating a long half-life
of SirT6 in the presence of CHIP. In contrast, proteasome inhibi-
tion in shCHIP cells resulted in a dramatic increase in WT SirT6
levels, similar to data in Fig. 1D and E. However, no MG132-
induced accumulation of K170R SirT6 was observed in shCHIP
cells, suggesting that the K170 residue is the predominant lysine
involved in the proteasome-mediated degradation of SirT6.
Our data in Fig. 1 to 4 demonstrate that CHIP promotes SirT6
stability, that CHIP directly interacts with SirT6 through CHIP’s
U-box domain, that reintroduction of ubiquitination-competent
CHIP increases SirT6 protein expression, that SirT6 is noncanoni-
cally ubiquitinated in the presence of CHIP, and that CHIP can
directly ubiquitinate SirT6 with noncanonical chains at K170. In
the absence of CHIP, WT SirT6 (but not K170R SirT6) is degraded
in a proteasome-dependent manner, suggesting that K170 is dec-
orated with canonical ubiquitin chains when CHIP is depleted.
Taken together, these data suggest a model in which CHIP com-
petes with a second ubiquitin ligase to noncanonically ubiquiti-
nate SirT6 at K170, preventing canonical ubiquitination at K170
and promoting SirT6 stabilization. Although the overwhelming
majority of CHIP substrates are degraded by the proteasome fol-
lowing canonical ubiquitination, the data presented here suggest a
new role for CHIP in protein stabilization.
CHIP’s stabilization of SirT6 results in decreased H3K9Ac
levels and increased transcription of target genes. In order to
understand the biochemical relevance of CHIP’s effect on SirT6
stability, we examined the levels of acetylated histone H3K9
(H3K9Ac), a target of SirT6 KDAC activity (30), in control and
CHIP-depleted cells. We hypothesized that, in the absence of
CHIP, decreased SirT6 steady-state levels (Fig. 1B) should lead to
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accumulation of H3K9Ac. Using 293 cells and MEFs, we found
that cells lacking CHIP also demonstrated increased H3K9Ac rel-
ative to total H3 (Fig. 5A).
SirT6 binds to the promoters of NF-B-dependent inflamma-
tory genes (31), hypoxia-inducible factor 1 (HIF-1)-dependent
glycolytic genes (32), and c-Jun-dependent IGF-related genes (26,
33), where SirT6 deacetylates H3K9Ac at these positions to inhibit
transcription of downstream gene products. Conversely, SirT6
deletion increases H3K9Ac promoter enrichment and enhances
transcription of these genes. Therefore, we hypothesized that the
decreased WT SirT6 protein half-life (Fig. 4B) and increased
H3K9Ac (Fig. 5A) measured in CHIP-deficient cells would corre-
spond to increased H3K9Ac at the promoters of SirT6-regulated
NF-B- and HIF-1-dependent genes. Furthermore, because
overexpression of WT CHIP in shCHIP cells increases SirT6 pro-
tein stability (Fig. 2E and F), we hypothesized that CHIP reintro-
duction in shCHIP cells would ameliorate the effects of CHIP
depletion. To obtain an unbiased understanding of how SirT6
depletion might affect H3K9Ac levels across the genome, we first
performed ChIP with next-generation sequencing analysis (ChIP-
seq) of H3K9Ac-enriched genomic regions. In silico analysis of
H3K9Ac-enriched genomic regions was performed using. Inge-
nuity pathway analysis and TRANSFAC to identify representation
in biological pathways and transcription factor binding sites, re-
spectively. Consistent with the hypothesis that decreased SirT6
stability in shCHIP cells would lead to increased H3K9Ac at the
promoters of SirT6 target genes, H3K9Ac enrichment was in-
creased in transcriptional networks associated with HIF-1 and
NF-B in shCHIP cells (Fig. 5B and C).
To directly demonstrate whether decreased SirT6 protein sta-
bility in shCHIP cells affects SirT6 and H3K9Ac enrichment at
promoters previously determined to demonstrate SirT6 occu-
pancy, we performed ChIP with real-time PCR (ChIP-qPCR) for
endogenous SirT6 and H3K9Ac at the promoters of several previ-
ously identified SirT6-regulated genes (31, 32) in shControl or
shCHIP cells or shCHIP cells transiently overexpressing WT
CHIP. In accordance with our data demonstrating an overall de-
crease in SirT6 and increase in H3K9Ac in CHIP-depleted cells,
SirT6 enrichment was dramatically decreased at promoter regions
in shCHIP cells (Fig. 5D), resulting in increased H3K9Ac enrich-
ment at these positions (Fig. 5E). However, compared with
shCHIP cells, CHIP overexpression in shCHIP cells slightly in-
creased SirT6 enrichment and, conversely, decreased H3K9Ac en-
richment. Since H3K9Ac promotes gene transcription, we ex-
pected that the mRNA of the genes controlled by these promoters
would also be increased in CHIP-deficient cells, as has been ob-
served in SirT6-depleted cells (31, 32). We found that mRNA lev-
els of several gene products of the promoters measured in Fig. 5D
and E were increased in shCHIP cells (Fig. 5F) and CHIP/
mouse livers (Fig. 5G); however, CHIP overexpression blunted
the effect of CHIP depletion on mRNA (Fig. 5F). The increase in
SirT6-regulated mRNAs in CHIP-depleted cells was directly de-
pendent on SirT6, as transient overexpression of either WT SirT6
or K170 SirT6 in shCHIP cells reduced mRNA levels to normal
(Fig. 5H and I). Taken together, these data indicate that CHIP
increases SirT6 stability, but in the absence of CHIP, the reduction
in SirT6 protein half-life leads to decreased SirT6 promoter occu-
pancy, causing increased H3K9Ac promoter occupancy and in-
creased transcription of inflammatory and glycolytic genes. Thus,
CHIP prevents aberrant NF-B- and HIF-1-dependent gene
transcription by stabilizing SirT6, a negative regulator of these
transcription factors.
CHIP and SirT6 are required for resistance to cellular stress.
In addition to SirT6’s role in transcriptional regulation, SirT6 also
enhances base excision repair and double-strand break (DSB) re-
pair by activating poly(ADP-ribose) polymerase 1, stabilizing
DNA-PK, and deacetylating CtIP (34–36). Therefore, we explored
whether CHIP depletion and subsequent effects on SirT6 protein
stability also affect DNA repair mediated through SirT6. We first
measured the effects of multiple DNA-damaging agents on viabil-
ity and DSBs in CHIP/ and CHIP/ MEFs. As shown in Fig.
6A, CHIP/ cells demonstrated higher toxicity when exposed to
3-aminobenzamide, camptothecin, or paraquat. Quantification
of 
H2AX foci (an indicator of DSBs) showed that significantly
more CHIP/ cells had increased numbers of foci per cell than
CHIP/ cells (Fig. 6B and C). To further test whether the loss
of CHIP is associated with reduced DNA repair capacity, we ex-
posed 293 cells to the DNA-damaging agent MMS or H2O2 and
found that shCHIP 293 cells demonstrated less viability (Fig. 6D
and E). However, this decrease in viability was directly linked to a
decrease in SirT6 in these cells, as SirT6 overexpression in
shCHIP-expressing cells (shCHIP plus SirT6) increased viability
(Fig. 6D) or caused a trend toward increased viability (Fig. 6E).
SirT6 depletion is associated with reduced phosphorylation of
RPA, which is recruited to DNA repair sites and is a marker of
successful homologous recombination (34). In accordance with
our cell viability data, we found that RPA phosphorylation was
decreased in shCHIP cells treated with MMS (Fig. 6F) or H2O2
(Fig. 6G). However, ectopic expression of WT SirT6 or K170R
SirT6 in CHIP-depleted cells restored RPA phosphorylation lev-
els. Although a plethora of proteins are involved in DNA damage
response pathways, the viability and DNA damage phenotype
produced in the absence of CHIP is strikingly similar to the phe-
notype reported for SirT6-depleted cells (34, 35) and indicates
that CHIP is required for maximum SirT6-mediated DNA repair
activity. The sum total of the data presented here demonstrate that
the convergence of CHIP- and SirT6-related functions represents
an intersection between PQC and epigenetics that supports the
foundation for signaling associated with longevity.
DISCUSSION
Cells possess complicated networks of quality control systems that
facilitate the production and repair of functional nucleic acids and
proteins. In the later stages of an organism’s life span, by-products
of normal molecular processes and damage from environmental
insults gradually overwhelm the cell’s ability to effectively coun-
teract these stresses, which can lead to early senescence and the
eventual deterioration of entire organ systems. The data presented
here reveal a previously unknown intersection between two qual-
ity control systems that work in unison to facilitate the surveil-
lance and repair of damage that would otherwise compromise
cellular integrity. Our observations suggest that the ubiquitin li-
gase CHIP noncanonically ubiquitinates the sirtuin family mem-
ber SirT6 at K170 and, by doing so, stabilizes and protects SirT6
from proteasome-dependent degradation mediated by a second,
as yet undetermined ubiquitin ligase. This allows SirT6 to partic-
ipate in histone deacetylation and DNA repair pathways (Fig. 7).
Although the stable interaction between CHIP and SirT6 and ev-
idence of ubiquitination from in vitro assays would indicate a di-
rect mechanism for CHIP’s effects on SirT6 stability, it is possible
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FIG 6 Decreased DNA repair in the absence of CHIP is rescued with SirT6 overexpression. (A) CHIP/ (white bars) and CHIP/ (black bars) MEFs were
cultured in DMSO, 3-aminobenzamide (3-AB), camptothecin (CTT), or paraquat (PRQ), and viability was assessed using an MTS assay (n  3). (B) Following
drug treatment, MEFs were fixed and stained for 
H2AX and DAPI, and foci of 90 nuclei/condition were quantified. The results were clustered by the number
of foci per cell and expressed as percentages of the total distribution. (C) Representative images from 
H2AX (green) staining. DAPI (blue) is included as a
nuclear stain. (D and E) shControl and shCHIP cells stably expressing empty vector or FLAG-SirT6 were treated with MMS (D) or H2O2 (E) for 6 days. The cells
were stained with trypan blue and counted, and the percentage of viable cells was calculated (n  3). (F and G) shControl and shCHIP cells were transiently
transfected with vector, WT SirT6, or K170R SirT6. Forty-eight hours later, the cells were exposed to 200 M MMS (F) or 400 M H2O2 (G) for 1 h and then
allowed to recover for 30 min. Cells were harvested, and the levels of total RPA and RPA phosphorylated at serines 4 and 8 were measured via Western blotting.
Quantification of phosphorylated RPA normalized to total RPA is shown below the representative blots (n  4 for each). The results represent means and SEM;
*, P  0.05.
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that CHIP stabilizes SirT6 through an indirect mechanism, such
as degrading an E3 ligase that ubiquitinates SirT6 in the absence of
CHIP. Future work will focus on identifying other factors in-
volved in SirT6 stability and their potential regulation by CHIP. In
addition, it is important that we use mass spectrometry methods
to directly confirm ubiquitination of SirT6 at K170 and solidify
evidence that the presence of CHIP affects ubiquitin chain link-
ages associated with SirT6.
Aging cells experience reduced DNA repair activity and in-
creased DNA lesions, and several progeria syndromes are charac-
terized by major deficiencies in DNA repair proteins (37). SirT6
augments DNA repair processes and preserves genomic integrity
by interacting with multiple DNA repair proteins (34–36), includ-
ing the telomere-associated protein WRN, which specifically pre-
vents telomere shortening and early cell senescence (30). Addi-
tionally, SirT6 KDAC activity targeting H3K9Ac blocks the
transcription of genes regulated by the NF-B subunit p65, as well
as genes associated with glycolysis, glucose transport, and IGF
signaling (26, 27, 31, 32), which are upregulated during aging (38,
39). Given these roles for SirT6, it is not surprising that a large
portion of SirT6/ mice demonstrate perinatal lethality due to
dysregulation of glucose homeostasis (27). Similar to our obser-
vations of CHIP/ mice (5), SirT6/ mice that survive the peri-
natal period are smaller than WT littermates and exhibit a prema-
ture-aging phenotype characterized by loss of subcutaneous fat,
decreased bone mineral density, lordokyphosis, and increased se-
nescence-associated -galactosidase staining (25). Although the
average life span of SirT6/ mice is substantially shorter than
that of CHIP/ mice, the similarity in the phenotypes is striking.
Given the data demonstrating that SirT6 protein is dramatically
decreased in CHIP/ cells and tissues, it is likely that the loss of
SirT6 in CHIP/ mice is partially responsible for the dramatic
aging phenotype observed in CHIP/ mice.
The original discovery of CHIP has yielded many studies iden-
tifying substrates that are canonically ubiquitinated by CHIP and
subsequently targeted to the proteasome for degradation (10, 13,
14). However, there is ample evidence demonstrating CHIP’s ca-
pability to produce a variety of ubiquitin chains, both canonical
and noncanonical in nature, and proteasomal degradation is not
necessarily the result of CHIP-mediated ubiquitination (15, 40).
The mechanics and biology of noncanonical ubiquitin chains are
not fully understood, but our current understanding suggests that
noncanonical chains have diverse effects on substrate protein lo-
calization, activity, and interactions with other proteins (16). Our
recent work demonstrating that CHIP noncanonically ubiquiti-
nates and sequesters Daxx describes a noncanonical ubiquitina-
tion event but is an example of how CHIP inhibits the activity of a
ubiquitinated substrate (17). The data presented here also dem-
onstrate CHIP’s ability to noncanonically ubiquitinate the target
substrate SirT6. However, in contrast to the biology of Daxx,
CHIP-mediated SirT6 ubiquitination increases SirT6 stability and
supports catalytic activity. Given that this is the second demon-
stration of CHIP-mediated noncanonical ubiquitination, it is pos-
sible that CHIP modifies other substrates in a similar manner. It
will be exciting to identify other CHIP ubiquitination substrates
and to determine whether their fate is degradation or stabilization.
In summary, we have identified SirT6 as a substrate for CHIP-
dependent noncanonical ubiquitination, which improves SirT6
stability and enhances SirT6 activity in supporting DNA repair
and reducing transcription of inflammatory and glycolytic genes.
The discovery of the CHIP-SirT6 interaction provides a bridge
between protein homeostasis and epigenetic regulation, two net-
works essential to understanding the molecular biology of aging.
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